RecruitingSystemic Lupus Erythematosus of Childhood (Disorder)
Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus
Eligible age
12–22 yrs
Accepts
All genders
Locations
6 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This study aims to investigate the feasibility and effectiveness of a cognitive behavioral coping skills program, Treatment and Education Approach for Childhood-onset Lupus (TEACH), for youth with cSLE when integrated into medical care. This TEACH program aims to teach participants skills in order to cope with fatigue, pain, and depressive symptoms--symptoms that commonly affect adolescents and young adults with lupus.
Sponsor: Michigan State University
You may qualify if…
- ✓ 1\) be diagnosed with cSLE, meeting the revised American College of Rheumatology Classification Criteria for SLE by age 18 years
- ✓ 2\) be between the ages of 12 and 22 years
- ✓ 3\) in recognition of the heterogeneity of cSLE symptoms, have elevations in fatigue (i.e., T scores ≥60; or at least moderate symptoms, on the PROMIS measure) OR depressive symptoms (≥5 on the PHQ-9, T Score ≥ 60 on the BDI or CDI II ), OR pain (i.e., average pain ≥3 out of 10 on the Pain VAS)
- ✓ 4\) have English language proficiency (their primary caregiver can have English or Spanish language proficiency for the child to enroll)
- ✓ 5\) those under age 18 years (US), or 16 years (Canada) must have a consenting caregiver
You may not qualify if…
- ✕ 1\) other chronic medical conditions (e.g., juvenile arthritis)
- ✕ 2\) a documented developmental delay, severe cognitive impairment, or thought disorder
- ✕ 3\) an untreated major psychiatric illness (e.g., bipolar disorder, psychosis, severe depression (PHQ9 score ≥21, BDI/CDI II \> 90) or active suicidal ideation (SI), based on the Pediatric Health Questionnaire (PHQ-9) items plus clinical interview; see Measures section)
Where it's recruiting
Source: ClinicalTrials.gov · NCT06232304 · last updated 2025-10-30